Westwood-Squibb Announces $1 Million Grant To Establish Center For Dermatology Research At Wake Forest University

August 03, 1998

CHICAGO, Ill., Aug. 2, 1998 -- Westwood-Squibb Pharmaceuticals announced today that it is underwriting the establishment of a center for dermatology research at the Wake Forest University School of Medicine with a five-year, $1 million research grant.

The center will focus on health services research in dermatology, said Steven R. Feldman, M.D., Ph.D., associate professor of dermatology and pathology, and the center's director.

"For years most dermatology research in medical centers has focused on basic biochemical research," Feldman said, "leaving clinical research to pharmaceutical companies and ignoring altogether the economic, ethical, and policy issues that are critical to the practice of dermatology on a day-to-day basis.

"With this grant and the establishment of the Westwood-Squibb Center for Dermatology Research, we will be able to address some of these issues."

Officials with Wake Forest University, in Winston-Salem, N.C., and Westwood-Squibb of Buffalo, N.Y., made the announcement during the summer meeting of the American Academy of Dermatology.

Milton E. Goggans, the president of Westwood-Squibb Pharmaceuticals, said that Wake Forest University is a fitting home for the research center, given the internationally recognized leadership of Joseph Jorizzo, M.D., the chairman of Wake Forest's Department of Dermatology, in advancing the field of dermatology. It is also fitting that Westwood-Squibb underwrite the center, he said.

"Since its inception, Westwood-Squibb has been the leading company supporting dermatology," Goggans said. "This center is a bold step designed to assure the future of dermatology through research that is of practical value both to dermatologists and their patients, and we are proud to be affiliated with it."

The center will be administered as a research program within the Department of Dermatology of the Wake Forest University School of Medicine. In addition to serving as director, Feldman will be the center's principal investigator. Alan B. Fleischer, M.D., associate professor of dermatology at the school, will be co-director. Its official title will be the Westwood-Squibb Center for Dermatology Research.

The center will have two missions:

Much of the center's initial research will examine the shift toward managed care since 1990 and its impact on dermatology.

In one of the Westwood-Squibb Center's first research efforts, Fleischer showed that dermatologists are the most accurate and cost efficient providers of treatment for treating fungal skin disease.

His analysis of office visits for fungal skin disease from 1990 through 1994 showed that non-dermatologists tended to prescribe less-effective medications that cost the nation's health care system $10.3 to $24.9 million more than the more-effective, less-costly medications prescribed by 95 percent of the dermatologists.

Fleischer's findings were published in the July issue of the Journal of the American Academy of Dermatology.

And in the August issue of the same journal, Feldman examines the role of dermatologists in managed care environments and how managed-care organizations could improve skin care through expanded use of dermatological expertise.

Jorizzo, who was instrumental in establishing the critical mass of research at Wake Forest that made the Westwood-Squibb Center for Dermatology Research possible, said that the center will accelerate the school's ability to provide timely research that can tangibly improve people's lives through the promotion of better skin care.

"The funding from Westwood-Squibb will provide the seeds of growth for an even larger research program within the center supported by federal and industry sources," he said. "The challenges facing dermatology today call for both leadership and research, and in partnership with Westwood-Squibb, we hope to provide both."
-end-


Wake Forest Baptist Medical Center

Related Medicine Articles from Brightsurf:

An ultrasonic projector for medicine
A chip-based technology that modulates intensive sound pressure profiles with high resolution opens up new possibilities for ultrasound therapy.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

How dinosaur research can help medicine
The intervertebral discs connect the vertebrae and give the spine its mobility.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Moving beyond 'defensive medicine'
Study shows removing liability concerns slightly increases C-section procedures during childbirth.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Protein injections in medicine
One day, medical compounds could be introduced into cells with the help of bacterial toxins.

Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine
Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to 'conventional medicine'.

Read More: Medicine News and Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.